Abstract Book - PDF - San Antonio Breast Cancer Symposium

CTRC-AACR San Antonio Breast Cancer Symposium
P3-14-02
Withdrawn
P3-14-03 Differences in pathological and biological factors between
DCIS, DCIS with microinvasion (DCIS-MI) and DCIS with
concomitant invasive ductal carcinoma (DCIS-IDC)
MacGrogan G, Baranzelli MC, Picquenot JM, Penault-Llorca F,
Mathieu MC, Tas P, Fermeaux V, Mery E, Sagan C, Blanc-Fournier C,
Brabencova E, Arnould L, Jacquemier J, Ettore F, Velasco V, Gonzalves
B, Brouste V, Tunon de Lara C. Institut Bergonié, Bordeaux, France;
Centre Oscar Lambret, Lille, France; Centre Henri Becquerel, Rouen,
France; Centre Jean Perrin, Clermont-Ferrand, France; Institut
Gustave Roussy, Villejuif, France; Centre Eugène Marquis, Rennes,
France; CHU de Limoges, Limoges, France; Institut Claudius Regaud,
Toulouse, France; Centre René Gauducheau, Saint Herblain, France;
Centre François Baclesse, Caen, France; Institut Jean Godinot, Reims,
France; Centre Georges François Leclerc, Dijon, France; Institut Paoli
Calmettes, Marseille, France; Centre Antoigne Lacassagne, Nice,
France.
P3-14-04 Symptomatic DCIS is a risk factor for invasion and should be
managed accordingly
Dimopoulos N, Williams K, Kirwan CC, Johnson R, Howe M, Bundred
NJ. University Hospital of South Manchester.
P3-14-05 Recurrence in Patients Diagnosed with Ductal Carcinoma In
Situ: Predictors and Prognostic Significance
Sue GR, Killelea B, Horowitz NR, Lannin DR, Chagpar AB. Yale
University School of Medicine, New Haven, CT.
P3-14-06 The Utility of Margin Index To Predict Residual DCIS Following
Breast Conserving Surgery
Aneja S, Lannin DR, Killelea B, Horowitz NR, Chagpar AB. Yale
University School of Medicine, New Haven, CT.
Ongoing Trials 2: Surgery/Nodes
OT2-1-01 Feasibility of sentinel node detection after neoadjuvant
chemotherapy for patient with proved axillary lymph node
involvement: the French prospective multiinstitutional GANEA
2 ongoing trial
Classe J-M, Bordes V, Gimbergues P, Tunon de Lara C, Faure C,
Belichard C, Houpeau J-L, Raro P, Dupré P-F, Houvenaeghel G,
Barranger E, Marchal F, Deblay P, Rouanet P, Lefebvre C, Bourcier C,
Alran S. Institut de Cancerologie de l’Ouest, Nantes Saint Herblain,
France; Centre Jean Perrin, Clermont-Ferrand, France; Institut
Bergonié, Bordeaux, France; Centre Leon Berard, Lyon, France;
Centre Huguenin, Saint Cloud, France; Centre Oscar Lambret, Lille,
France; Centre Hospitalier Universitaire Morvan, Brest, France; Paoli
Calmettes, Marseille, France; CHU Lariboisière, Paris, France; Centre
Alexis Vautrin, Nancy, France; Centre